Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Selectis Health (GBCS) Gross Profit (2018 - 2025)

Selectis Health's Gross Profit history spans 8 years, with the latest figure at $2.3 million for Q3 2025.

  • For Q3 2025, Gross Profit fell 4.99% year-over-year to $2.3 million; the TTM value through Sep 2025 reached $9.5 million, up 18.35%, while the annual FY2024 figure was $9.1 million, 68.91% up from the prior year.
  • Gross Profit for Q3 2025 was $2.3 million at Selectis Health, up from $2.3 million in the prior quarter.
  • Across five years, Gross Profit topped out at $4.5 million in Q2 2022 and bottomed at $1.1 million in Q1 2023.
  • The 5-year median for Gross Profit is $2.2 million (2021), against an average of $2.2 million.
  • The largest annual shift saw Gross Profit surged 228.92% in 2022 before it tumbled 66.32% in 2023.
  • A 5-year view of Gross Profit shows it stood at $1.3 million in 2021, then skyrocketed by 59.89% to $2.1 million in 2022, then plummeted by 31.51% to $1.5 million in 2023, then surged by 73.28% to $2.5 million in 2024, then dropped by 8.31% to $2.3 million in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Gross Profit are $2.3 million (Q3 2025), $2.3 million (Q2 2025), and $2.4 million (Q1 2025).